Point72 Middle East FZE’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-9,400
Closed -$1.17M 401
2023
Q4
$1.17M Sell
9,400
-1,800
-16% -$184K 0.03% 559
2023
Q3
$1.04M Buy
11,200
+10,100
+918% +$1.14M 0.03% 558
2023
Q2
$141K Buy
1,100
+900
+450% +$109K ﹤0.01% 1142
2023
Q1
$23.2K Buy
+200
New +$22.4K ﹤0.01% 1404

Other funds holding DXCM

Point72 Middle East FZE's DXCM Position: Q1 2024 in Review

Point72 Middle East FZE sold out of DexCom (DXCM) in Q1 2024, closing a stake of 39,190 shares — an estimated $4.86M sold.

Point72 Middle East FZE first reported a position in DXCM in Q4 2022 and held it in 5 quarters. The position peaked at $16.3M in Q3 2023. 1,033 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

  • Point72 Middle East FZE reported no remaining DexCom position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 39,190 DexCom shares in Q1 2024, an estimated $4.86M.
  • Point72 Middle East FZE first reported a position in DexCom in Q4 2022 and held it in 5 quarters.
  • Point72 Middle East FZE's DexCom position peaked at $16.3M in Q3 2023.
  • 1,033 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.